Trial Profile
Maintenance Treatment of Chidamide in Chemotherapy-responded Stage IV or Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary)
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 23 Aug 2018 New trial record